Context Non Current Assets Total vs Deferred Long Term Liab Analysis
| CNTX Stock | USD 1.02 0.07 6.42% |
Context Therapeutics financial indicator trend analysis is way more than just evaluating Context Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Context Therapeutics is a good investment. Please check the relationship between Context Therapeutics Non Current Assets Total and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Context Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.
Non Current Assets Total vs Deferred Long Term Liab
Non Current Assets Total vs Deferred Long Term Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Context Therapeutics Non Current Assets Total account and Deferred Long Term Liab. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Context Therapeutics' Non Current Assets Total and Deferred Long Term Liab is -0.34. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Context Therapeutics, assuming nothing else is changed. The correlation between historical values of Context Therapeutics' Non Current Assets Total and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Context Therapeutics are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Non Current Assets Total i.e., Context Therapeutics' Non Current Assets Total and Deferred Long Term Liab go up and down completely randomly.
Correlation Coefficient | -0.34 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Most indicators from Context Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Context Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Context Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.Selling General Administrative is likely to rise to about 9.1 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 31 M in 2024.
Context Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Context Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Context Stock Analysis
When running Context Therapeutics' price analysis, check to measure Context Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Context Therapeutics is operating at the current time. Most of Context Therapeutics' value examination focuses on studying past and present price action to predict the probability of Context Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Context Therapeutics' price. Additionally, you may evaluate how the addition of Context Therapeutics to your portfolios can decrease your overall portfolio volatility.